Venture Visionary Partners LLC Purchases 297 Shares of CME Group Inc. (NASDAQ:CME)

Venture Visionary Partners LLC increased its position in CME Group Inc. (NASDAQ:CME) by 0.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 33,797 shares of the financial services provider’s stock after purchasing an additional 297 shares during the quarter. Venture Visionary Partners LLC’s holdings in CME Group were worth $7,458,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Salomon & Ludwin LLC bought a new stake in shares of CME Group in the 1st quarter valued at about $28,000. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the 2nd quarter worth approximately $36,000. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. grew its position in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Finally, Asset Dedication LLC boosted its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Analyst Ratings Changes

CME has been the topic of a number of research analyst reports. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research report on Thursday, October 3rd. The Goldman Sachs Group lifted their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Barclays raised their price target on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a report on Monday, October 7th. Finally, Bank of America boosted their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $220.07.

Insider Activity at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Performance

CME traded down $1.27 during midday trading on Monday, reaching $227.05. The company had a trading volume of 1,130,977 shares, compared to its average volume of 1,937,872. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $81.75 billion, a PE ratio of 25.97, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.12. The business has a 50-day moving average price of $216.92 and a two-hundred day moving average price of $208.32.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.30 earnings per share. On average, sell-side analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.